Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check7 days agoChange DetectedFooter updates include Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 text were removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedIPD data-sharing section updated: Ipsen's data transparency link was added and data availability timing clarified. References to Vivli were removed.SummaryDifference0.3%

- Check36 days agoChange DetectedPublications section updated to clarify that publications are automatically filled from PubMed and added Revision: v3.3.2. The prior PubMed-source phrasing and Revision: v3.2.0 reference were removed.SummaryDifference0.1%

- Check43 days agoChange DetectedNotice about potential outdated information due to a lapse in government funding has been removed from the page. Previously, the banner warned that information may not be up to date and that responses to inquiries could be delayed.SummaryDifference0.3%

- Check57 days agoChange DetectedDate-only updates were made to the Study Record Dates (e.g., 2025-10-29, 2025-10-27) with earlier dates removed. These are routine timestamp updates and do not modify trial design, eligibility, or results.SummaryDifference0.5%

- Check65 days agoChange DetectedAdded an estimated 'Last Update Posted' timestamp with new dates (2025-09 and 2025-10) and removed earlier entries (2025-07 and 2025-08).SummaryDifference0.2%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.